SCHEMBL24776296

SCHEMBL24776296

Clc1cc(N2CCOCC2)c2occc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
JAK2 O60674 1/20 0.46
ABL1 P00519 1/20 0.46
INSR P06213 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
RET P07949 1/20 0.46
MST1 P26927 1/20 0.46
TTK P33981 1/20 0.46
SYK P43405 1/20 0.46
MAPK8 P45983 1/20 0.46
TNK2 Q07912 1/20 0.46
MAP4K2 Q12851 1/20 0.46
NTRK2 Q16620 1/20 0.46
NCF1 P14598 2/20 0.46
PIK3CD O00329 1/20 0.45
PIK3CA P42336 1/20 0.45
KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31283928 1.00 MAPT (0.47) MAPTCYP1A2CYP2D6JAK2ABL1
SCHEMBL30818705 0.81 HRH3 (0.41) CYP2D6KMT2AMEN1NPC1RAB9A
SCHEMBL4733419 0.78 NCF1 (0.74) MAPTNCF1KMT2AGAASMN1; SMN2
SCHEMBL31283496 0.75 MAPT (0.42) MAPTCYP1A2CYP2D6NCF1KMT2A
SCHEMBL31283908 0.75 PIK3CA (0.47) MAPTCYP1A2JAK2ABL1INSR
SCHEMBL24776906 0.75 PIK3CA (0.47) MAPTCYP1A2JAK2ABL1INSR
SCHEMBL189922 0.75 SMN1; SMN2 (0.49) MAPTCYP1A2JAK2ABL1INSR
SCHEMBL24776656 0.74 KMT2A (0.42) MAPTCYP1A2CYP2D6NCF1KMT2A
SCHEMBL31284037 0.74 KMT2A (0.42) MAPTCYP1A2CYP2D6NCF1KMT2A
SCHEMBL23755331 0.73 PIK3CA (0.47) MAPTCYP1A2CYP2D6JAK2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256299-A1 7-MORPHOLINO-5-(3-PHENYL-1 H-PYRAZOL-1 -YL)-FURO[3,2-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PIKFYVE KINASE INHIBITORS FOR THE TREATMENT OF E.G. AMYOTROPHIC LATERAL SCLEROSIS (ALS) Verge Analytics, Inc. (US) 2022-12-08 WO disclosed